Naturex (EPA:NRX) and Shop Apotheke Europe (ETR:SAE) are both consumer defensive companies, but which is the better stock? We will contrast the two businesses based on the strength of their profitability, risk, institutional ownership, valuation, dividends, analyst recommendations and earnings.
Valuation & Earnings
This table compares Naturex and Shop Apotheke Europe's revenue, earnings per share and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio |
---|
Naturex | N/A | N/A | N/A | N/A | N/A |
Shop Apotheke Europe | $968.06 million | 3.39 | $-20,918,040.00 | (€1.17) | -156.69 |
Naturex has higher earnings, but lower revenue than Shop Apotheke Europe.
Analyst Recommendations
This is a breakdown of recent ratings and recommmendations for Naturex and Shop Apotheke Europe, as provided by MarketBeat.com.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score |
---|
Naturex | 0 | 0 | 0 | 0 | N/A |
Shop Apotheke Europe | 1 | 4 | 7 | 0 | 2.50 |
Shop Apotheke Europe has a consensus price target of €199.75, suggesting a potential upside of 9.33%. Given Shop Apotheke Europe's higher possible upside, analysts plainly believe Shop Apotheke Europe is more favorable than Naturex.
Profitability
This table compares Naturex and Shop Apotheke Europe's net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets |
---|
Naturex | N/A | N/A | N/A |
Shop Apotheke Europe | N/A | N/A | N/A |
Summary
Shop Apotheke Europe beats Naturex on 3 of the 3 factors compared between the two stocks.